Vanguard Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Hold |
190,761
| – | – | ﹤0.01% | 3636 |
|
|
2025
Q1 | $1.13M | Buy |
190,761
+11,979
| +7% | +$71.2K | ﹤0.01% | 3673 |
|
|
2024
Q4 | $2.38M | Sell |
178,782
-1,933
| -1% | -$25.7K | ﹤0.01% | 3510 |
|
|
2024
Q3 | $1.47M | Buy |
180,715
+11,379
| +7% | +$92.5K | ﹤0.01% | 3655 |
|
|
2024
Q2 | $1.44M | Sell |
169,336
-31,182
| -16% | -$265K | ﹤0.01% | 3671 |
|
|
2024
Q1 | $3.48M | Sell |
200,518
-66,924
| -25% | -$1.16M | ﹤0.01% | 3425 |
|
|
2023
Q4 | $3.43M | Buy |
267,442
+3,205
| +1% | +$41.1K | ﹤0.01% | 3422 |
|
|
2023
Q3 | $9.78M | Sell |
264,237
-13,616
| -5% | -$504K | ﹤0.01% | 2897 |
|
|
2023
Q2 | $11.2M | Buy |
277,853
+3,646
| +1% | +$147K | ﹤0.01% | 2876 |
|
|
2023
Q1 | $19.9M | Sell |
274,207
-14,235
| -5% | -$1.03M | ﹤0.01% | 2584 |
|
|
2022
Q4 | $23.7M | Buy |
288,442
+24,182
| +9% | +$1.98M | ﹤0.01% | 2543 |
|
|
2022
Q3 | $25M | Sell |
264,260
-27,663
| -9% | -$2.61M | ﹤0.01% | 2538 |
|
|
2022
Q2 | $56.9M | Buy |
291,923
+15,420
| +6% | +$3M | ﹤0.01% | 2139 |
|
|
2022
Q1 | $64.2M | Sell |
276,503
-6,518
| -2% | -$1.51M | ﹤0.01% | 2180 |
|
|
2021
Q4 | $112M | Buy |
283,021
+10,998
| +4% | +$4.33M | ﹤0.01% | 1928 |
|
|
2021
Q3 | $122M | Buy |
272,023
+3,857
| +1% | +$1.73M | ﹤0.01% | 1877 |
|
|
2021
Q2 | $104M | Buy |
268,166
+14,054
| +6% | +$5.46M | ﹤0.01% | 1981 |
|
|
2021
Q1 | $91.2M | Buy |
254,112
+28,581
| +13% | +$10.3M | ﹤0.01% | 1998 |
|
|
2020
Q4 | $111M | Buy |
225,531
+33,561
| +17% | +$16.5M | ﹤0.01% | 1780 |
|
|
2020
Q3 | $62.2M | Buy |
191,970
+6,265
| +3% | +$2.03M | ﹤0.01% | 1903 |
|
|
2020
Q2 | $67.6M | Buy |
185,705
+32,812
| +21% | +$12M | ﹤0.01% | 1849 |
|
|
2020
Q1 | $32.5M | Buy |
152,893
+5,625
| +4% | +$1.2M | ﹤0.01% | 2058 |
|
|
2019
Q4 | $60.6M | Buy |
147,268
+4,010
| +3% | +$1.65M | ﹤0.01% | 2012 |
|
|
2019
Q3 | $50.6M | Buy |
143,258
+22,794
| +19% | +$8.05M | ﹤0.01% | 2057 |
|
|
2019
Q2 | $60.6M | Buy |
120,464
+5,291
| +5% | +$2.66M | ﹤0.01% | 2000 |
|
|
2019
Q1 | $114M | Buy |
115,173
+2,515
| +2% | +$2.5M | ﹤0.01% | 1681 |
|
|
2018
Q4 | $97.8M | Buy |
112,658
+13,155
| +13% | +$11.4M | ﹤0.01% | 1694 |
|
|
2018
Q3 | $103M | Buy |
99,503
+4,249
| +4% | +$4.39M | ﹤0.01% | 1788 |
|
|
2018
Q2 | $87.5M | Buy |
95,254
+31,980
| +51% | +$29.4M | ﹤0.01% | 1850 |
|
|
2018
Q1 | $61.7M | Buy |
63,274
+25,774
| +69% | +$25.1M | ﹤0.01% | 1964 |
|
|
2017
Q4 | $17M | Buy |
37,500
+774
| +2% | +$350K | ﹤0.01% | 2558 |
|
|
2017
Q3 | $15.2M | Buy |
36,726
+2,891
| +9% | +$1.2M | ﹤0.01% | 2607 |
|
|
2017
Q2 | $11.8M | Buy |
33,835
+558
| +2% | +$195K | ﹤0.01% | 2695 |
|
|
2017
Q1 | $17.1M | Buy |
33,277
+3,265
| +11% | +$1.68M | ﹤0.01% | 2502 |
|
|
2016
Q4 | $10.7M | Buy |
30,012
+1,970
| +7% | +$699K | ﹤0.01% | 2717 |
|
|
2016
Q3 | $15M | Buy |
28,042
+854
| +3% | +$457K | ﹤0.01% | 2499 |
|
|
2016
Q2 | $15.3M | Buy |
27,188
+4,590
| +20% | +$2.58M | ﹤0.01% | 2447 |
|
|
2016
Q1 | $10.8M | Sell |
22,598
-727
| -3% | -$346K | ﹤0.01% | 2579 |
|
|
2015
Q4 | $15.4M | Buy |
23,325
+563
| +2% | +$372K | ﹤0.01% | 2416 |
|
|
2015
Q3 | $17.9M | Buy |
22,762
+8,654
| +61% | +$6.8M | ﹤0.01% | 2335 |
|
|
2015
Q2 | $18.6M | Buy |
14,108
+5,448
| +63% | +$7.19M | ﹤0.01% | 2391 |
|
|
2015
Q1 | $9M | Buy |
8,660
+3,494
| +68% | +$3.63M | ﹤0.01% | 2693 |
|
|
2014
Q4 | $3.45M | Buy |
+5,166
| New | +$3.45M | ﹤0.01% | 3073 |
|